JPMorgan upgraded Welltower stock to Overweight at USD 260.00
Published on 10/12/2026 at 12:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- JPMorgan upgraded Welltower to Overweight and set a USD 260.00 price target on September 24, 2026.
- Second-quarter 2026 normalized FFO rose 25.00 percent to USD 1.60 per share.
- Second-quarter 2026 revenue increased 39.10 percent to USD 3.54 billion.
- Welltower stock was trading at EUR 202.25 at Lang & Schwarz on October 12, 2026.
- Welltower is an NYSE-listed healthcare facilities REIT and an S&P 500 member.
Welltower Inc. (ISIN US95040Q1040) was trading at EUR 202.25 at Lang & Schwarz on October 12, 2026 at 12:28 p.m. CEST. As MarketBeat reports, JPMorgan upgraded Welltower from Neutral to Overweight on September 24, 2026 and raised its price target from USD 230.00 to USD 260.00.
Three milestones shape the story
On July 27, 2026, Welltower reported second-quarter 2026 revenue of USD 3.54 billion and normalized funds from operations of USD 1.60 per diluted share, according to Financial Report Insights.
The same quarter produced a 25.00 percent year-over-year increase in normalized funds from operations per share and a 39.10 percent revenue increase. On September 24, JPMorgan's rating change added a USD 260.00 target, and on October 1, BMO Capital reiterated Buy with a USD 265.00 target, as reported by Markets Insider.
What does the growth mean?
The operating detail matters more than the headline revenue gain. In the second quarter of 2026, same-store Seniors Housing Operating net operating income grew 20.50 percent, while occupancy reached 89.40 percent from 86.10 percent a year earlier, according to Financial Report Insights.
Management also raised full-year 2026 normalized FFO guidance to USD 6.36-6.44 per diluted share from USD 6.21-6.35. The comparison shows the central investor question: whether occupancy, pricing and acquisitions can continue lifting per-share cash earnings as the portfolio expands.
Dates and market context
The next dated company event identified in the reviewed filing calendar is the expected October 27, 2026 filing of Welltower's third-quarter 2026 Form 10-Q, according to Ticker Scout. The date is presented as an expected filing date rather than a company-announced earnings date.
Welltower operates a healthcare real estate platform centered on seniors housing, post-acute care and outpatient medical properties. Its current profile includes more than 2,500 seniors and wellness housing communities across the United States, the United Kingdom and Canada.
Welltower stock at EUR 202.25
Welltower stock was trading at EUR 202.25 at Lang & Schwarz on October 12, 2026 at 12:28 p.m. CEST. The finance quote for the primary listing showed a USD 162.5 billion market capitalization and a USD 142.65 to USD 255.20 52-week range as of October 9, 2026.
The further course of trading is shown by the continuously updated real-time quote of Welltower stock.
Welltower stock facts
- Company: Welltower Inc.
- ISIN: US95040Q1040
- Ticker: WELL
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 12, 2026, 12:28 p.m. CEST): EUR 202.25
- Market capitalization: USD 162.5 billion (as of October 9, 2026)
- 52-week range: USD 142.65-255.20 (as of October 9, 2026)
- Sector / Industry: Real Estate / REIT - Healthcare Facilities
- Index membership: S&P 500
Market context: Market report S&P 500.
